Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Gynecologic Cancer
  Follow Topic   Edit Search
Your search returned 19 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
BMJ supportive & palliative care 
... improved cancer-specific quality of life for women following curative treatment for stage I-III gynaecological cancer AbstractText: Consecutive women were invited to participate in a randomised controlled study (HNA and care ... professional is cost-effective, acceptable and useful for some women treated for stage I-III gynaecological cancer... Keyword: gynaecological cancer.
Oncology (9)
Neoplasms (9), more mentions
Annals of oncology : official journal of the European Society for Medical Oncology
Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers)..
Oncology (2)
Endometrial Carcinoma (2), more mentions
Journal of pain and symptom management
... to validate the Korean-version MSAS-SF in patients with gynecologic cancer AbstractText: We translated the MSAS-SF into Korean and 175 gynecologic cancer inpatients completed the MSAS-SF, Functional Assessment Cancer Therapy-General ... a valid tool for the reliable assessment of patients with gynecologic cancer in Korea Keyword: Gynecologic neoplasm.
Oncology (8)
Neoplasms (7), Female Genital Neoplasms (1), more mentions
BJOG : an international journal of obstetrics and gynaecology
Re: A paradigm shift in the origin of ovarian cancer: the ovary is no longer to blame: Is the ovary to blame for tubal carcinoma?.
Oncology (2)
Ovarian Neoplasms (2), Carcinoma (2), more mentions
Cell 
DescriptorName: Ovarian Neoplasms... Abstract: We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases ...
Oncology (5)
Neoplasms (5), Ovarian Neoplasms (3), Neoplasm Metastasis (1), more mentions
BJOG : an international journal of obstetrics and gynaecology
Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study..
Cervical Intraepithelial Neoplasia (2), more mentions
BJOG : an international journal of obstetrics and gynaecology
Authors' reply re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study..
Cervical Intraepithelial Neoplasia (2), more mentions
Clinical cancer research : an official journal of the American Association for Cancer Research
Background Vulvar cancer (VC) can be sub-classified by human papilloma virus (HPV ... We comprehensively assessed somatic mutations in a large series of vulvar (pre)cancers... Results Frequent recurrent mutations were identified in HPV negative vulvar (pre)cancers in TP53 (42% and 68%), NOTCH1 (28% and 41%) and ... Mutation frequency in HPV positive vulvar (pre)cancers was significantly lower (p-value = 0.001.
Oncology (1)
Vulvar Neoplasms (1), Papilloma (1), Neoplasms (1), more mentions
Lancet (London, England)
... poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide ... based chemotherapy in patients with high-grade, recurrent, platinum-sensitive ovarian carcinoma.In this randomised, double-blind, placebo-controlled, phase 3 trial ... significantly improved progression-free survival in patients with platinum-sensitive ovarian cancer who had achieved a response to platinum-based chemotherapy.
Oncology (5)
Carcinoma (7), Ovarian Neoplasms (2), Neoplasms (2), more mentions
Obstetrics and gynecology
Patients who underwent ovarian, fallopian tube, or peritoneal cancer cytoreductive surgery at an academic tertiary care center from April ... 12/91 [13%]; P=.005) AbstractText: Infection is common after ovarian cancer cytoreductive surgery... 5-point surgical site infection prevention bundle in women undergoing ovarian cancer operations was associated with dramatically decreased infection rates and lower ...
Oncology (4), Infectious Diseases (2), Anti-Obesity and Weight Loss (1)
Infections (11), Ovarian Neoplasms (3), Neoplasms (1), more mentions
Annals of surgical oncology
... morbidity and overall survival (OS) in patients with advanced epithelial ovarian cancer (EOC) treated at a tertiary gynecologic cancer center AbstractText: Exploratory analysis of our prospectively documented tumor registry ... Data of all consecutive patients with stage IIIB-IV ovarian cancer who underwent primary cytoreductive surgery (PDS) from January 2000 to ...
Oncology (4)
Ovarian Neoplasms (3), Neoplasms (3), more mentions
Annals of surgical oncology
Abstract: The aim of this study was to review the surgical and clinical outcomes of intrathoracic and mediastinal surgical cytoreduction in stage IV epithelial ovarian cancer (EOC. Relevant articles were identified from MEDLINE and EMBASE. Only analyses or reports that described actual intrathoracic cytoreduction via pleurectomy and/or resection of cardiophrenic/mediastinal lymph nodes were included.
Oncology (2)
Ovarian Neoplasms (2), Neoplasms (2), Thoracic Diseases (1), more mentions
Lancet (London, England)
PARP inhibitors for targeted treatment in ovarian cancer..
Oncology (2)
Ovarian Neoplasms (2), more mentions
Radiology
Patients with known ovarian cysts or ovarian cancer at time of the index CT examination were excluded ... CI: 0.4%, 1.0%) of 2763 patients were found to have ovarian cancer after an average follow-up of 5.1 years ± 3.8 (range ... women with simple-appearing cysts were given a diagnosis of ovarian cancer.
Oncology (6)
Cysts (12), Ovarian Neoplasms (5), Ovarian Cysts (2), more mentions
Clinical cancer research : an official journal of the American Association for Cancer Research
... may serve as a unique tumor marker for HPV-associated malignancies, including cervical cancer... HPV DNA in patients with HPV16- or HPV18-positive metastatic cervical cancer for potential disease monitoring and treatment-related decision making.In ... HPV ccfDNA was measured in serum samples from 19 metastatic cervical cancer patients by duplex digital droplet (dd) PCR.
Oncology (7)
Neoplasms (7), Uterine Cervical Neoplasms (6), more mentions
Annals of oncology : official journal of the European Society for Medical Oncology
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up..
Oncology (2)
Uterine Cervical Neoplasms (2), more mentions
Sexually transmitted diseases
Of these clinics, 31 (39.7%) offered both cervical cancer screening and HPV vaccination, 6 (7.7%) offered cervical cancer screening only, 21 (26.9%) offered HPV vaccination only, and 20 (25.6%) offered neither cervical cancer prevention service ... not offering the service, the most commonly reported barrier to cervical cancer screening was time constraints (25/41, 61.0%); for HPV vaccination ...
Oncology (9)
Uterine Cervical Neoplasms (9), Sexually Transmitted Diseases (7), Infections (1), more mentions
JAMA internal medicine
Using Risk Stratification to Reduce Medical Errors in Cervical Cancer Prevention..
Oncology (2)
Uterine Cervical Neoplasms (2), more mentions
American journal of obstetrics and gynecology
A pilot study in using deep-learning to predict limited life-expectancy in women with recurrent cervical cancer..
Oncology (2)
Uterine Cervical Neoplasms (2), more mentions